BB Biotech AG (BION.S)
BION.S on Swiss Exchange
68.10CHF
18 Apr 2019
68.10CHF
18 Apr 2019
Change (% chg)
CHF-0.60 (-0.87%)
CHF-0.60 (-0.87%)
Prev Close
CHF68.70
CHF68.70
Open
CHF68.35
CHF68.35
Day's High
CHF69.15
CHF69.15
Day's Low
CHF67.85
CHF67.85
Volume
88,827
88,827
Avg. Vol
96,906
96,906
52-wk High
CHF74.60
CHF74.60
52-wk Low
CHF55.05
CHF55.05
About
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)
Overall
| Beta: | 1.13 |
| Market Cap(Mil.): | CHF3,772.74 |
| Shares Outstanding(Mil.): | 55.40 |
| Dividend: | 3.05 |
| Yield (%): | 4.85 |
Financials
| BION.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 109.48 | 62.40 |
| EPS (TTM): | -8.46 | -- | -- |
| ROI: | -14.68 | 7.96 | 11.78 |
| ROE: | -14.68 | 8.11 | 12.61 |
Swiss stocks - Factors to watch on April 12
ZURICH/BERLIN, April 12 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,543 points on Friday, according to premarket indications by bank Julius Baer .
BRIEF-BB Biotech Launches New Buyback Program
* SAID ON THURSDAY CONCLUDES ITS SHARE BUYBACK PROGRAM AND LAUNCHES A NEW BUYBACK PROGRAM
BRIEF-BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
* FY NET LOSS OF CHF 471 MN COMPARED TO A NET GAIN OF CHF 688 MN FOR FULL YEAR OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
BRIEF-BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
* BB BIOTECH INVESTS GAINS OF M&A TRANSACTIONS IN NEW TECHNOLOGIES - DIVIDEND OF CHF 3.05 PROPOSED
Estimates